ATE251167T1 - Oxazinocarbazole zur behandlung von cns- erkrankungen - Google Patents

Oxazinocarbazole zur behandlung von cns- erkrankungen

Info

Publication number: ATE251167T1
Authority: AT; Austria
Prior art keywords: oxazinocarbazoles; treatment; cns diseases; cns; diseases
Prior art date: 1999-07-28

Application number

AT00948738T

Other languages

English (en)

Inventor

Ruth E Tenbrink

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-28

Filing date

2000-07-20

Publication date

2003-10-15

2000-07-20 Application filed by Upjohn Co filed Critical Upjohn Co

2003-10-15 Application granted granted Critical

2003-10-15 Publication of ATE251167T1 publication Critical patent/ATE251167T1/de

Links

201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Diabetes (AREA)
Obesity (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Anesthesiology (AREA)
Psychology (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT00948738T 1999-07-28 2000-07-20 Oxazinocarbazole zur behandlung von cns- erkrankungen ATE251167T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US14601399P	1999-07-28	1999-07-28
PCT/US2000/019532 WO2001009142A1 (en)	1999-07-28	2000-07-20	Oxazinocarbazoles for the treatment of cns diseases

Publications (1)

Publication Number	Publication Date
ATE251167T1 true ATE251167T1 (de)	2003-10-15

Family

ID=22515535

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00948738T ATE251167T1 (de)	1999-07-28	2000-07-20	Oxazinocarbazole zur behandlung von cns- erkrankungen

Country Status (20)

Country	Link
US (2)	US6448397B1 (de)
EP (1)	EP1200447B1 (de)
JP (1)	JP2003506328A (de)
KR (1)	KR20020015079A (de)
CN (1)	CN1165539C (de)
AR (1)	AR024963A1 (de)
AT (1)	ATE251167T1 (de)
AU (1)	AU767282B2 (de)
BR (1)	BR0012791A (de)
CA (1)	CA2376927A1 (de)
CO (1)	CO5031298A1 (de)
DE (1)	DE60005685T2 (de)
DK (1)	DK1200447T3 (de)
ES (1)	ES2208371T3 (de)
MX (1)	MXPA02000984A (de)
PE (1)	PE20010548A1 (de)
PT (1)	PT1200447E (de)
TW (1)	TWI222450B (de)
WO (1)	WO2001009142A1 (de)
ZA (1)	ZA200110539B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100497122B1 (ko) *	2001-08-30	2005-06-29	주식회사 삼양제넥스	페놀옥시다제 시스템을 구성하는 단백질 및 그것의 유전자
SE0103539D0 (sv) *	2001-10-23	2001-10-23	Biovitrum Ab	New Use
EP1450806B1 (de) *	2001-11-09	2009-04-29	Biovitrum AB (publ)	Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
EP1495031A1 (de) *	2002-04-16	2005-01-12	Pharmacia & Upjohn Company LLC	Markierte oxazinocarbazole als diagnostikmittel
US6932961B1 (en)	2002-04-16	2005-08-23	Pharmacia & Upjohn Company	Oxazinocarbazoles for the treatment of CNS diseases
WO2004050085A1 (en) *	2002-12-03	2004-06-17	F. Hoffmann-La Roche Ag	Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
MX2008013053A (es)	2006-04-12	2008-10-17	Wyeth Corp	Derivados de dihidri[1,4]oxazino[2,3,4-hi]indazol-sustituidos como ligandos de 5-hidroxitriptamina-6.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3885357T2 (de)	1987-06-29	1994-03-24	Duphar Int Res	Anellierte Indolderivate.
GB8812636D0 (en) *	1988-05-27	1988-06-29	Glaxo Group Ltd	Chemical compounds
EP0377238A1 (de)	1988-12-22	1990-07-11	Duphar International Research B.V	Annelierte Indolo(3,2-c)-lactame
KR960705824A (ko)	1993-10-20	1996-11-08	아사이 이페이	인돌 유도체(Indole Derivative)
EP0985671B1 (de)	1996-05-31	2003-04-02	Mochida Pharmaceutical Co., Ltd.	PYRIDOCARBAZOL DERIVATE DIE EINEN cGMP-PDE INHIBILIERENDEN EFFEKT HABEN

2000
- 2000-07-19 TW TW089114437A patent/TWI222450B/zh active
- 2000-07-20 CA CA002376927A patent/CA2376927A1/en not_active Abandoned
- 2000-07-20 PT PT00948738T patent/PT1200447E/pt unknown
- 2000-07-20 US US09/620,493 patent/US6448397B1/en not_active Expired - Fee Related
- 2000-07-20 ES ES00948738T patent/ES2208371T3/es not_active Expired - Lifetime
- 2000-07-20 DE DE60005685T patent/DE60005685T2/de not_active Expired - Fee Related
- 2000-07-20 DK DK00948738T patent/DK1200447T3/da active
- 2000-07-20 KR KR1020027001118A patent/KR20020015079A/ko not_active Ceased
- 2000-07-20 CN CNB008104573A patent/CN1165539C/zh not_active Expired - Fee Related
- 2000-07-20 EP EP00948738A patent/EP1200447B1/de not_active Expired - Lifetime
- 2000-07-20 WO PCT/US2000/019532 patent/WO2001009142A1/en not_active Ceased
- 2000-07-20 MX MXPA02000984A patent/MXPA02000984A/es active IP Right Grant
- 2000-07-20 AT AT00948738T patent/ATE251167T1/de not_active IP Right Cessation
- 2000-07-20 JP JP2001513949A patent/JP2003506328A/ja active Pending
- 2000-07-20 AU AU62197/00A patent/AU767282B2/en not_active Ceased
- 2000-07-20 BR BR0012791-4A patent/BR0012791A/pt not_active IP Right Cessation
- 2000-07-25 PE PE2000000747A patent/PE20010548A1/es not_active Application Discontinuation
- 2000-07-26 CO CO00056117A patent/CO5031298A1/es unknown
- 2000-07-27 AR ARP000103887A patent/AR024963A1/es unknown
2001
- 2001-12-21 ZA ZA200110539A patent/ZA200110539B/xx unknown
2002
- 2002-05-16 US US10/146,970 patent/US6821970B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1200447B1 (de)	2003-10-01
TWI222450B (en)	2004-10-21
PT1200447E (pt)	2004-02-27
EP1200447A1 (de)	2002-05-02
DE60005685T2 (de)	2004-08-12
WO2001009142A1 (en)	2001-02-08
US20020169317A1 (en)	2002-11-14
CN1361781A (zh)	2002-07-31
MXPA02000984A (es)	2002-07-30
CA2376927A1 (en)	2001-02-08
BR0012791A (pt)	2002-06-18
AU767282B2 (en)	2003-11-06
AU6219700A (en)	2001-02-19
AR024963A1 (es)	2002-10-30
CO5031298A1 (es)	2001-04-27
KR20020015079A (ko)	2002-02-27
US6821970B2 (en)	2004-11-23
ES2208371T3 (es)	2004-06-16
JP2003506328A (ja)	2003-02-18
PE20010548A1 (es)	2001-05-13
DK1200447T3 (da)	2004-02-02
US6448397B1 (en)	2002-09-10
ZA200110539B (en)	2003-03-24
CN1165539C (zh)	2004-09-08
DE60005685D1 (de)	2003-11-06

Legal Events

Date

Code

Title

Description

2004-04-15

UEP

Publication of translation of european patent specification

Ref document number: 1200447

Country of ref document: EP

2007-04-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60019556D1 (de)	2005-05-25	2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE308997T1 (de)	2005-11-15	Mittel zur behandlung von erkrankungen der speiseröhre
DE60019555D1 (de)	2005-05-25	2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60023128D1 (de)	2006-02-23	Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69903543D1 (de)	2002-11-21	Formulierungen zur behandlung von magen-speiseröhren reflux
ATE275145T1 (de)	2004-09-15	Chinazolinderivate zur behandlung von tumoren
DE60019158D1 (de)	2005-05-04	Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60123238D1 (de)	2006-11-02	Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60136477D1 (de)	2008-12-18	Retinoide zur behandlung von emphysem
ATE384522T1 (de)	2008-02-15	Medikamente zur chemotherapeutischen behandlung von erkrankungen
DE60204466D1 (de)	2005-07-07	Integrinhemmer zur behandlung von augenkrankheiten
ATE279386T1 (de)	2004-10-15	Retinoide zur behandlung von emphysem
DE50013843D1 (de)	2007-01-18	Arzneimittel zur behandlung von darmerkrankungen
DE60035326D1 (de)	2007-08-09	Verfahren zur Behandlung von Abwasser
DE60238765D1 (de)	2011-02-10	Carbamatverbindungen zur behandlung von schmerz
DE50105735D1 (de)	2005-04-28	Chlorzoxazon zur behandlung von psoriasis
DE60016047D1 (de)	2004-12-23	Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60021252D1 (de)	2005-08-18	Antikonvulsiva zur behandlung von autismus
ATE253578T1 (de)	2003-11-15	Oxazinochinolone zur behandlung von viralen infektionen
DE69913380D1 (de)	2004-01-15	Zusammensetzung zur behandlung von periodontalen erkrankungen
ATE230741T1 (de)	2003-01-15	3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
ATE251167T1 (de)	2003-10-15	Oxazinocarbazole zur behandlung von cns- erkrankungen
DE60017174D1 (de)	2005-02-03	Rivastigmine zur behandlung von augenerkrankungen
DE60043648D1 (de)	2010-02-25	Medikamente zur behandlung von periodontalen erkrankungen